Prolonged hypocalcemia after treatment with zoledronic acid in a patient with prostate cancer and vitamin D deficiency

被引：35

作者：

Breen, TL ^{[1
]}

Shane, E ^{[1
]}

机构：

[1] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 08期

关键词：

D O I：

10.1200/JCO.2004.99.013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1531 / 1532

页数：2

共 11 条

[1] A dose-finding study of zoledronate in hypercalcemic cancer patients [J].

Body, JJ ;

Lortholary, A ;

Romieu, G ;

Vigneron, AM ;

Ford, J .

JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (09) :1557-1561

[2] Hypocalcemia following pamidronate administration for bone metastases of solid tumor: Three clinical case reports [J].

Champallou, C ;

Basuyau, JP ;

Veyret, C ;

Chinet, P ;

Debled, M ;

Chevrier, A ;

Grongnet, MH ;

Brunelle, P .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2003, 25 (02) :185-190

[3] Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population [J].

Harris, SS ;

Soteriades, E ;

Coolidge, JAS ;

Mudgal, S ;

Dawson-Hughes, B .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) :4125-4130

[4] The new bisphosphonate, Zometa® (Zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions:: A comparison to pamidronate [J].

Lipton, A ;

Small, E ;

Saad, F ;

Gleason, D ;

Gordon, D ;

Smith, M ;

Rosen, L ;

Kowalski, MO ;

Reitsma, D ;

Seaman, J .

CANCER INVESTIGATION, 2002, 20 :45-54

[5] Zoledronic acid in the treatment of hypercalcemia of malignancy: Results of the international clinical development program [J].

Major, PP ;

Coleman, RE .

SEMINARS IN ONCOLOGY, 2001, 28 (02) :17-24

[6] Intravenous zoledronic acid in postmenopausal women with low bone mineral density. [J].

Reid, IR ;

Brown, JP ;

Burckhardt, P ;

Horowitz, Z ;

Richardson, P ;

Trechsel, U ;

Widmer, A ;

Devogelaer, J ;

Kaufman, J ;

Jaeger, P ;

Body, J ;

Meunier, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) :653-661

[7] Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency [J].

Rosen, CJ ;

Brown, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (15) :1503-1504

[8] Treatment of bone complications in advanced prostate cancer: Rationale for bisphosphonate use and results of a phase III trial with zoledronic acid [J].

Saad, F .

SEMINARS IN ONCOLOGY, 2002, 29 (06) :19-27

[9] Hypocalcemia associated with alendronate [J].

Schussheim, DH ;

Jacobs, TP ;

Silverberg, SJ .

ANNALS OF INTERNAL MEDICINE, 1999, 130 (04) :329-329

[10] Hypovitaminosis D in medical inpatients [J].

Thomas, MK ;

Lloyd-Jones, DM ;

Thadhani, RI ;

Shaw, AC ;

Deraska, DJ ;

Kitch, BT ;

VAmvakas, EC ;

Dick, IM ;

Prince, RL ;

Finkelstein, JS .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (12) :777-783

← 1 2 →